Several biologic studies have reported that green tea constituents have antitumor effects on hematologic malignancies. However, the effects in humans are uncertain. The authors used data from the Ohsaki National Health Insurance Cohort Study in Japan to evaluate the association between green tea consumption and the risk of hematologic malignancies. Study participants were 41,761 Japanese adults aged 40-79 years without a history of cancer at baseline who answered a food frequency questionnaire survey in 1994. During 9 years of follow-up beginning in 1995, the authors documented 157 hematologic malignancies, including 119 cases of lymphoid neoplasms and 36 cases of myeloid neoplasms. Hazard ratios were calculated by using the Cox proportional hazards regression model. Risk of hematologic malignancies was inversely associated with green tea consumption. The multivariate-adjusted hazard ratio of hematologic malignancies for 5 cups/day or more compared with less than 1 cup/day of green tea was 0.58 (95% confidence interval: 0.37, 0.89). The corresponding risk estimate was 0.52 (95% confidence interval: 0.31, 0.87) for lymphoid neoplasms and 0.76 (95% confidence interval: 0.32, 1.78) for myeloid neoplasms. This inverse association was consistent across sex and body mass index strata. In conclusion, green tea consumption was associated with a lower risk of hematologic malignancies.
Hematologic malignancies are known to have a wide geographic distribution; incidence rates are relatively high in Western countries and low throughout Asia, including Japan and developing countries (1) . According to ''Global Cancer Statistics, 2002'' by Parkin et al. (1) , age-standardized incidence rates per 100,000 for non-Hodgkin lymphoma were higher than 10.0 for men and 6.5 for women in North America and in western, northern, and southern Europe, while they were lower than 6.5 for men and 4.0 for women in eastern and southern Asia, including Japan. Similarly, the rates of Hodgkin lymphoma were higher than 2.0 in North and Central America and in Europe and lower than 1.0 in southeastern Asia (1) . The reasons for this discrepancy are still unclear. Many epidemiologic studies have explored the risk factors for hematologic malignancies. Cigarette smoking (2) (3) (4) (5) , high alcohol consumption (5), obesity (6) (7) (8) (9) , height (6), occupational exposures (10) , infection with some viruses, and immunodeficiency (11) (12) (13) are thought to induce some types of hematologic malignancies. However, preventive factors for hematologic malignancies are not well known and are a public health concern because the incidence of hematologic malignancies has been increasing worldwide (1) .
Currently, there is extensive interest in the health benefits of green tea. Thus, green tea and its major constituent, tea polyphenols, have been widely studied as preventive factors for various diseases, including cancers (14) (15) (16) (17) (18) (19) (20) . Several biologic studies have reported that green tea constituents, such as (-)-epigallocatechin-3-gallate (EGCG), exert antitumor effects against hematologic malignancies by inducing apoptosis and/or suppressing angiogenesis (21) (22) (23) (24) (25) . However, epidemiologic studies on this topic have been few; to our knowledge, only 3 case-control studies have been conducted (26) (27) (28) . Two reported that green tea intake was associated with a lower risk of leukemia (26, 28) , and another study reported that higher intake of tea flavonoids was inversely associated with the risk of non-Hodgkin lymphoma (27) .
This evidence may help explain the low incidence of hematologic malignancies in Asian countries, where consumption of green tea is the highest in the world. However, further evidence from cohort studies or intervention trials is needed to obtain some consensus on this issue. We therefore designed this population-based cohort study to investigate the association between green tea consumption and the risk of hematologic malignancies in a rural area of Japan, where green tea is widely consumed.
MATERIALS AND METHODS

Study cohort
We conducted a population-based cohort study based on data from the Ohsaki National Health Insurance (NHI) Cohort, the details of which have been described previously (29) (30) (31) . In brief, from October through December 1994, we delivered self-administered questionnaires, including items on dietary intake, to all NHI beneficiaries aged 40-79 years living in the catchment area of the Ohsaki Public Health Center, Miyagi Prefecture, in northeastern Japan. The Ohsaki Public Health Center, a local government agency, provides preventive health services for residents of 14 municipalities in the northern part of Miyagi Prefecture. The study area is a typical rural area of Japan, where the main industry is agriculture.
Of 54,996 eligible individuals, 52,029 returned usable questionnaires; the response rate was 94.6%. We started prospective collection of the NHI withdrawal history files on January 1, 1995, to ascertain the date of and reason for withdrawal from NHI. We excluded 776 participants who had withdrawn from NHI before the baseline questionnaire survey. Thus, 51,253 participants (24,573 men and 26,680 women) were finally entered into the study as our cohort participants. The ethics committee of Tohoku University School of Medicine reviewed and approved the study protocol. We considered the return of self-administered questionnaires signed by the participants to imply their consent to take part in the study.
For the current analysis, we excluded 7 participants (1 man and 6 women) who had incomplete data in the cancer incidence registry, as well as 3,148 participants (1,557 men and 1,591 women) who, as ascertained from self-reports and the cancer registry, had been diagnosed as having cancer before the baseline survey was conducted. We also excluded 6,337 participants (3,266 men and 3,071 women) who had provided incomplete responses regarding frequency of green tea consumption. Consequently, we entered data for 41,761 eligible participants (19,749 men and 22,012 women) into our analysis.
Dietary assessment
We assessed dietary intake of participants at the baseline survey by using the self-administered questionnaire, which included a food frequency questionnaire (FFQ). In this FFQ, we asked participants to report their frequency of recent consumption of 36 food items and 4 beverages, including green tea. The FFQ provided 5 categories of response to describe participants' frequency of green tea consumption: never, occasionally, 1-2 cups/day, 3-4 cups/day, and 5 cups/ day or more. The volume of a typical cup of green tea was 100 mL in the study region (19) . The questionnaire also consisted of items on personal and family history of disease, physical status, drinking and smoking habits, and occupational and educational status.
We conducted a validation study of the FFQ, as reported previously (32) . Spearman's rank coefficient for the correlation between green tea consumption as assessed by the FFQ and four 3-day food records was 0.71 for men and 0.53 for women, and the correlation between consumption measured by 2 FFQs administered 1 year apart was 0.63 for men and 0.64 for women. We examined the total energy intake of each participant from the FFQ responses by converting the selected frequency category for each food to daily intake, using portion sizes based on the median values observed in the validation study (32) .
Ascertainment of cases and follow-up
The endpoint of our analysis was the incidence of all hematologic malignancies defined by morphology codes 9590 We ascertained the incidence of cancer through computerized record linkage to the Miyagi Prefecture Cancer Registry, one of the oldest and most accurate population-based cancer registries in Japan (35) . Between 1993 and 1997, the percentages registered by death certificates only were, for lymphoma, 23% for men and 21% for women and, for leukemia, 36% for men and 37% for women (35) .
We prospectively counted person-years of follow-up for each of the participants from January 1, 1995, until the date of diagnosis of hematologic malignancies, the date of withdrawal from NHI, the date of death, or the end of the followup period (December 31, 2003), whichever occurred first. For follow-up, we periodically reviewed the NHI withdrawal history files. When a participant in this study withdrew from the NHI system because of death, emigration, or occupational change, the date of withdrawal and the reason were coded in the files. Follow-up of participants who had withdrawn from the NHI system was discontinued because we were unable to obtain subsequent information on them. During the study period, 5,427 participants (2,147 men and 3,280 women: 13.0% of the total) were lost to follow-up.
Statistical analysis
We combined the lower 2 categories of green tea consumption (never, occasionally) into the single category ''less than 1 cup/day'' for the purpose of this analysis because of the small number of participants and cases in each category. We used the Cox proportional hazards regression model to estimate hazard ratios and 95% confidence intervals for the incidence of hematologic malignancies according to levels of green tea consumption and to adjust for potential confounding variables, using SAS version 9.1 statistical software (SAS Institute, Inc., Cary, North Carolina). We calculated incidence rates of hematologic malignancies by dividing the number of incident cases by the number of person-years in each stratum of green tea consumption. The hazard ratio was computed as the incidence rate among participants in each green tea consumption stratum divided by the rate among participants in the lowest intake stratum (less than 1 cup/day), which was chosen as the reference group. All hazard ratios were calculated as age and sex adjusted and as multivariate adjusted. The P values for the test of linear trends were calculated by scoring the green tea consumption category as an ordinal variable (less than 1 cup/day ¼ 1-5 cups/day or more ¼ 4). All reported P values were 2-sided, and the estimates with P < 0.05 were considered statistically significant. We also conducted additional analyses after categorizing hematologic malignancies as lymphoid neoplasms and myeloid neoplasms.
We evaluated and compared the risk across sex and body mass index strata to assess whether any impact of green tea consumption on the risk of hematologic malignancies differed across sex and/or obesity status. To avoid any possible bias resulting from the influence of undiagnosed cancers present at baseline, we repeated the analysis after excluding participants who had been given a diagnosis of cancer within the first 3 years of follow-up and started follow-up from January 1, 1998, 3 years from the baseline date.
We considered the following variables to be potential confounders prior to the analyses: age (continuous variable, years), sex, family history of leukemia (yes or no), history of blood transfusion (yes or no), job status (nonfarmers or farmers, including former farmers), educational level (less than high school, high school, some college or higher), height (155, 155-164, 165 cm), body mass index (<18.5, 18.5-24.9, 25.0 kg/m 2 ), cigarette smoking (never smoked, former smoker, current smoker of <20 cigarettes/ day, current smoker of 20 cigarettes/day), alcohol drinking (never drank, former drinker, current drinker of <45.6 g ethanol/day, current drinker of 45.6 g ethanol/day), fish consumption (2 times/week, 3-4 times/week, every day), soybean products consumption (2 times/week, 3-4 times/ week, every day), daily miso soup consumption (yes or no), coffee consumption (never, occasionally, 1 cup/day), and total caloric intake (continuous variable, kcal/day). To avoid overfitting a model, we included these variables apart from age and sex in our final multivariate-adjusted model as confounders only if each variable met both of the following criteria: 1) it was associated with both green tea consumption and risk of hematologic malignancies (i.e., the probabilities of being exposed and diseased varied more than 5% among the strata of a potential confounder); and 2) after adding the variable into the age-and sex-adjusted model, the hazard ratio point estimate changed more than 1%. In the FFQ, alcohol consumption was classified in terms of ''go,'' a traditional Japanese unit for measuring the amount of alcoholic beverages equal to approximately 180 mL of sake, containing 22.8 g of ethanol.
RESULTS
Participants who consumed more green tea than others tended to be older and were more likely to consume fish and soybean products, the typical sources of protein in the Japanese traditional daily diet (Table 1) . Meat consumption was not associated with green tea consumption (data not shown). Men, but not women, who consumed more green tea were less likely to be heavy alcohol drinkers and obese. Furthermore, participants who consumed more green tea were more likely to smoke less, but this association was not obvious when we stratified them by sex.
During 326,012 person-years of follow-up (154,348 person-years for men and 171,664 person-years for women; mean ¼ 7.8, maximum ¼ 9.0 years), we documented 157 hematologic malignancies (in 88 men and 69 women); included were 119 cases of lymphoid neoplasms (66 men and 53 women) and 36 cases of myeloid neoplasms (20 men and 16 women). We found a significant inverse association between green tea consumption and the risk of hematologic malignancies in our participants ( Table 2 ). The multivariateadjusted hazard ratios for the incidence of hematologic malignancies were 0.88 (95% confidence interval: 0.57, 1.38) for 1-2 cups/day, 0.90 (95% confidence interval: 0.59, 1.39) for 3-4 cups/day, and 0.58 (95% confidence interval: 0.37, 0.89) for 5 cups/day or more (P for trend ¼ 0.02) compared with less than 1 cup/day of green tea consumption. After dividing all hematologic malignancies into lymphoid neoplasms and myeloid neoplasms, we observed similar trends in the former, but not the latter, group.
We observed associations similar to those in our primary analysis across the strata of sex and body mass index (Table 3) . Furthermore, the likelihood ratio tests between the models with and without interaction were not statistically significant for both sex and body mass index; the P values were 0.80 and 0.99, respectively. Because the numbers of participants and cases in the body mass index stratum of less than 18.5 kg/m 2 were very small, we integrated it and the stratum of 18.5-24.9 kg/m 2 into a new stratum of less than 25.0 kg/m 2 in this stratified analysis. The risks did not change considerably after we started follow-up 3 years after the baseline date (data not shown).
DISCUSSION
We observed a significant inverse association between green tea consumption and the risk of hematologic malignancies during 9 years of follow-up in a large populationbased cohort of Japanese that included 157 cases of hematologic malignancies. This association was more apparent for lymphoid neoplasms after we categorized hematologic malignancies as lymphoid and myeloid neoplasms. Compared with participants who consumed less than 1 cup/day of green tea, those who consumed 5 cups/day or more had a 42% lower risk of hematologic malignancies and a 48% lower risk of lymphoid neoplasms.
To our knowledge, this population-based cohort study is the first to find an association between green tea consumption and hematologic malignancies; no cohort study and only 3 case-control studies have been known to assess the relation between consumption of green tea or its constituents and hematologic malignancies. In a study from China, longer duration, higher quantity, and frequency of green tea intake were associated with a reduced risk for 107 leukemia cases and 110 controls (26) . A study from the United States reported that higher intake of epicatechins, one of the flavonoids present richly in green tea, was associated with lower risk of non-Hodgkin lymphoma in 466 cases and 390 controls (27) . The most recent case-control study of 252 leukemia cases and 637 controls from Taiwan reported an inverse association between green tea consumption and the risk of leukemia for individuals aged 16-29 years (28) . These results were consistent with those of our study; however, case-control studies are not free from selection bias or recall bias related to retrospective measurement of exposure and other possible confounding factors after a diagnosis of disease. a P values for trend were calculated by treating the green tea consumption categories as an ordinal variable and as 2-sided.
b Less than 1 cup/day was chosen as the reference group. c Adjusted for age (continuous variable, years), sex, educational level (<high school, high school, college), cigarette smoking (never smoked, former smoker, current smoker of <20 cigarettes/day, current smoker of 20 cigarettes/day), alcohol drinking (never drank, former drinker, current drinker of <45.6 g ethanol/day, current drinker of 45.6 g ethanol/day), fish consumption (2 times/week, 3-4 times/week, every day), and soybean products consumption (2 times/week, 3-4 times/week, every day).
Recent animal and in vitro studies have reported that green tea and some of its constituents, especially EGCG, have antitumor activities against several types of hematologic malignancies. For instance, green tea inhibited angiogenesis and induced apoptosis in animal models of human non-Hodgkin lymphoma (21); EGCG suppressed vascular endothelial growth factor production and induced apoptosis in chronic lymphocytic leukemia B cells (22) ; EGCG induced apoptotic cell death in malignant B cells in vitro (23) ; EGCG induced apoptotic cell death in human a P values for trend were calculated by treating the green tea consumption categories as an ordinal variable and as 2-sided.
b Less than 1 cup/day was chosen as the reference group. c Adjusted for age (continuous variable, years), sex, educational level (<high school, high school, college), cigarette smoking (never smoked, former smoker, current smoker of <20 cigarettes/day, current smoker of 20 cigarettes/day), alcohol drinking (never drank, former drinker, current drinker of <45.6 g ethanol/day, current drinker of 45.6 g ethanol/day), fish consumption (2 times/week, 3-4 times/week, every day), and soybean products consumption (2 times/week, 3-4 times/week, every day). The model stratified by sex did not include the variable for sex.
lymphoblastoid B cells through several pathways, such as production of intracellular reactive oxygen species (24) ; and EGCG and some of the other green tea catechins inhibited matrix metalloproteinase-9 secretion, thus affecting myeloid cell differentiation and angiogenesis (25) . Furthermore, a clinical case report documented antitumor effects of oral green tea extracts in 4 patients with low-grade B-cell malignancies (36) . This evidence supports our results and might explain the mechanisms of the observed association of green tea with a reduced incidence of hematologic malignancies.
Our present results indicate that the preventive effect of green tea consumption against hematologic malignancies seems to have a threshold effect rather than a dose-response effect. The lower risks of hematologic malignancies were obvious only in the group consuming 5 cups or more of green tea daily (Tables 2 and 3 ). This result is inconsistent with recent biologic studies indicating a dose-dependent manner of green tea constituents against hematologic tumor cells (22) (23) (24) (25) . These discrepancies between animal experiments and our epidemiologic observations might be due to differences in species, metabolism of green tea constituents, accuracy of exposure measurement, degree of confounding and/or bias, and essential differences in study design. Moreover, although we observed that green tea consumption was inversely associated with the incidence of all hematologic malignancies as a whole and lymphoid neoplasms, we were unable to find any significant association with myeloid neoplasms alone. Because the number of cases of myeloid neoplasm in this study was very small, we were unable to conclude whether this lack of association was due to insufficient statistical power or to pathogenetic differences between malignant lymphoid and myeloid cells, such as differences in sensitivity to green tea constituents or in the mechanisms of development, proliferation, and/or differentiation.
Infection with human immunodeficiency virus, human T-cell leukemia virus type-1, and Epstein-Barr virus is an established risk factor for hematologic malignancies (11) (12) (13) . Although we were unable to acquire any information about such viral infections in our participants, infection with human immunodeficiency virus and human T-cell leukemia virus type-1 is very rare in this region (37, 38) ; Japan is known to have a relatively high rate of human T-cell leukemia virus type-1 infection, but the endemic area is southern Japan, far from our study area. Epstein-Barr virus is widespread throughout the world, and most adults in any country are seropositive against Epstein-Barr virus antigen (38) . We thus considered that our inability to assess infection with such viruses would not substantially distort our result.
Our study had some limitations. First, 13% of all participants were lost to follow-up. Nevertheless, this proportion did not vary across the 4 green tea consumption categories: the proportions of participants lost to follow-up at the lowest to highest green tea consumption levels were 14%, 14%, 13%, and 12%.
Second, the number of cases of hematologic malignancies among our participants was modest in comparison with the Western population. Therefore, we were unable to evaluate the association between green tea consumption and risk of each subtype of hematologic malignancy (e.g., Hodgkin lymphomas, non-Hodgkin lymphomas, lymphoid leukemias, or myeloid leukemias), even though the risk factors probably vary according to subtype.
Third, the quality and completeness of the Miyagi Cancer Registry were not high enough regarding hematologic malignancies: the level of death-certificate-only diagnosed lymphoma and leukemia was higher than 20%. Such a fairly high proportion of death-certificate-only cases might have led to failure to ascertain some individuals who had hematologic malignancies but did not die during the study period.
Fourth, we were unable to obtain enough information related to occupational exposures, ionizing radiation, benzene, and so forth, which may affect the risk of hematologic malignancies (10) . Even though we added a variety of potential confounders to our analysis, there were a considerable number of unmeasured confounders.
Finally, we excluded 6,337 participants from our analysis because they provided incomplete answers for, or did not answer the question on, green tea consumption. In this excluded group, 31 cases of hematologic malignancies were diagnosed. Because the distribution of baseline characteristics among those participants was similar to that among participants in the lowest green tea consumption stratum (data not shown), we assumed that they were likely to consume no or less green tea. Using this assumption, we conducted a sensitivity analysis after including those participants in the lowest stratum of green tea consumption. The result of this analysis did not differ from that of our primary analysis: the multivariate-adjusted hazard ratios were 0.86 (95% confidence interval: 0.57, 1.30), 0.90 (95% confidence interval: 0.61, 1.34), and 0.58 (95% confidence interval: 0.39, 0.87) for 1-2, 3-4, and 5 cups/day or more, respectively, compared with less than 1 cup/day.
We previously reported that green tea consumption was not associated with risk of gastric cancer (39, 40) , breast cancer (41), colorectal cancer (42), prostate cancer (43) , and lung cancer (44) . Hematologic malignancies are the first and only malignant tumors for which we have derived a significant inverse association with green tea consumption. The differences in evidence between our previous studies and the present one indicate that hematologic malignancies may have specific characteristics that result in a response to certain green tea components.
We concluded that green tea consumption was inversely associated with the risk of hematologic malignancies in the general rural population of Japan. Our results have implications for not only primary prevention of hematologic malignancies but also treatment and/or recurrence prevention. Further biologic studies and clinical trials are necessary to confirm the role of green tea in prevention and treatment of hematologic malignancies.
